atorvastatin has been researched along with Intermittent Claudication in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Mehta, A; Sperling, LS; Wells, BJ | 1 |
| Amsterdam, EA; Armstrong, EJ; Choy, HK; Foley, TR; Kokkinidis, DG; Laird, JR; Pham, T; Rutledge, JC; Singh, GD; Waldo, SW | 1 |
| Antova, E; Bosevska, G; Bosevski, M; Krstevski, G; Mitevska, I | 1 |
| Bregar, U; Jug, B; Poredos, P; Sabovic, M; Sebestjen, M | 1 |
| Buszman, PE; Buszman, PP; Kiesz, RS; Konkolewska, MD; Martin, JL; Radvany, MG; Szymanski, R; Wiernek, BK; Wiernek, SL | 1 |
| Creager, MA; Hiatt, WR; Mohler, ER | 1 |
2 trial(s) available for atorvastatin and Intermittent Claudication
| Article | Year |
|---|---|
The influence of atorvastatin on walking performance in peripheral arterial disease.
Topics: Aged; Anticholesteremic Agents; Arterial Occlusive Diseases; Atorvastatin; Cholesterol, LDL; Combined Modality Therapy; Diet, Fat-Restricted; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Intermittent Claudication; Male; Middle Aged; Pyrroles; Statistics, Nonparametric; Walking | 2009 |
Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol; Double-Blind Method; Exercise Test; Exercise Tolerance; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intermittent Claudication; Male; Peripheral Vascular Diseases; Prospective Studies; Pyrroles; Quality of Life; Treatment Outcome; Walking | 2003 |
4 other study(ies) available for atorvastatin and Intermittent Claudication
| Article | Year |
|---|---|
Postexercise Ankle-Brachial Index Testing.
Topics: Ankle Brachial Index; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Exercise; Exercise Test; Exercise Therapy; Female; Humans; Intermittent Claudication; Lisinopril; Middle Aged; Peripheral Arterial Disease | 2020 |
High-Intensity Statin Therapy Is Associated With Improved Survival in Patients With Peripheral Artery Disease.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angiography; Atorvastatin; Biomarkers; Critical Illness; Disease Progression; Disease-Free Survival; Drug Prescriptions; Dyslipidemias; Endovascular Procedures; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Lipids; Male; Middle Aged; Peripheral Arterial Disease; Practice Patterns, Physicians'; Registries; Retrospective Studies; Risk Factors; Rosuvastatin Calcium; Time Factors; Treatment Outcome | 2017 |
Hyperfibrinogenemia in Peripheral Arterial Disease: Coexistent and Independent Risk Factor (A Report of Two Cases and Review of Literature).
Topics: Amputation, Surgical; Anticholesteremic Agents; Atorvastatin; Diabetes Mellitus, Type 2; Fenofibrate; Fibrinogen; Humans; Hypolipidemic Agents; Intermittent Claudication; Ischemia; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Predictive Value of Tests; Risk Factors; Treatment Outcome | 2018 |
Long-term results of plaque excision combined with aggressive pharmacotherapy in high-risk patients with advanced peripheral artery disease (SAVE a LEG registry).
Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Aspirin; Atherectomy; Atorvastatin; Cardiovascular Agents; Clopidogrel; Combined Modality Therapy; Critical Illness; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrroles; Recurrence; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Ticlopidine; Time Factors; Treatment Outcome | 2013 |